Day: June 7, 2020

First healthy volunteer has been dosed in a Phase I study of JS016, the first SARS-CoV-2 neutralizing antibody to enter the clinical stage in ChinaJunshi and Lilly will co-develop JS016 globallyJS016 is a recombinant fully human monoclonal neutralizing antibody that blocks the binding of the SARS-CoV-2 virus to the host cell surface receptor ACE2SHANGHAI, China, June 07, 2020 (GLOBE NEWSWIRE) — Junshi Biosciences (HKEX: 1877), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, today announced that the first healthy volunteer has been dosed in the Phase I clinical study of JS016 at Huashan Hospital Affiliated to Fudan University in China. JS016 is the first SARS-CoV-2 neutralizing antibody to enter clinical trials in China. Junshi and Eli Lilly...

VANCOUVER, British Columbia, June 07, 2020 (GLOBE NEWSWIRE) — SouthGobi Resources Ltd. (TSX: SGQ, HK: 1878) (“SouthGobi” or the “Company”) announces that SGS and First Concept entered into a settlement agreement on June 7, 2020 (the “Settlement Agreement”).Reference is made to the announcement of the Company dated June 2, 2020 in relation to the enforcement on Arbitration Award (“Announcement”). Unless the context otherwise requires, capitalized terms used herein shall have the same meanings as those defined in the Announcement. Pursuant to the Settlement Agreement, SGS shall pay to First Concept a settlement sum in full and final settlement of any and all claims which First Concept may have against SGS in relation to Arbitration Award, the subject matter of the Arbitration Award including any claims for interests and costs and...